Literature DB >> 12171936

The stereoenantiomers of a pinacidil analog open or close cloned ATP-sensitive K+ channels.

Ulf Lange1, Cornelia Löffler-Walz, Heinrich C Englert, Annette Hambrock, Ulrich Russ, Ulrich Quast.   

Abstract

ATP-dependent K(+) channels (K(ATP) channels) are composed of pore-forming subunits Kir6.x and sulfonylurea receptors (SURs). Cyanoguanidines such as pinacidil and P1075 bind to SUR and enhance MgATP binding to and hydrolysis by SUR, thereby opening K(ATP) channels. In the vasculature, openers of K(ATP) channels produce vasorelaxation. Some novel cyanoguanidines, however, selectively reverse opener-induced vasorelaxation, suggesting that they might be K(ATP) channel blockers. Here we have analyzed the interaction of the enantiomers of a racemic cyanoguanidine blocker, PNU-94750, with Kir6.2/SUR channels. In patch clamp experiments, the R-enantiomer (PNU-96293) inhibited Kir6.2/SUR2 channels (IC(50) approximately 50 nm in the whole cell configuration), whereas the S-enantiomer (PNU-96179) was a weak opener. Radioligand binding studies showed that the R-enantiomer was more potent and that it was negatively allosterically coupled to MgATP binding, whereas the S-enantiomer was weaker and positively coupled. Binding experiments also suggested that both enantiomers bound to the P1075 site of SUR. This is the first report to show that the enantiomers of a K(ATP) channel modulator affect channel activity and coupling to MgATP binding in opposite directions and that these opposite effects are apparently mediated by binding to the same (opener) site of SUR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171936     DOI: 10.1074/jbc.M206685200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibition.

Authors:  U Russ; P Kühner; R Prager; D Stephan; J Bryan; U Quast
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

2.  Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitor.

Authors:  Murali Gopalakrishnan; Thomas R Miller; Steven A Buckner; Ivan Milicic; Eduardo J Molinari; Kristi L Whiteaker; Rachel Davis-Taber; Victoria E Scott; Christopher Cassidy; James P Sullivan; William A Carroll
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.